ROIV - Roivant announces $1.5B share buyback positive Phase 2 data
2024-04-02 09:20:47 ET
More on Roivant Sciences
- Roivant Sciences: $7bn Televant Sale Sets It Up For Long-Term Success
- Roivant Sciences Ltd. (ROIV) Q3 2023 Earnings Call Transcript
- Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas
- Roivant Sciences Q3 2024 Earnings Preview
- Arbutus Biopharma gains after Markman hearing on Thursday in Moderna dispute